Sermorelin Dosing & Reconstitution Guide
Dosing Protocol
Route: Subcutaneous Frequency: Once daily (typically before bed) Dose Range: 100–300 mcg/day SC Cycle Length: 3–6 months; 1 month off between cycles Timing: Before bed on empty stomach (amplifies natural GH pulse during sleep)
Reconstitution
Vial Size: 5mg Water Volume: 2.5mL Concentration: 2mg/mL
Titration Schedule
Weeks 1–2: 100 mcg before bed Weeks 3–4: 200 mcg before bed Weeks 5+: 200–300 mcg before bed
Timeline & Pharmacokinetics
Onset: 15–30 minutes Peak Plasma: ~5–20 minutes (GH pulse peaks ~30–60 min after injection) Half-Life: ~10–20 minutes Steady State: 2–4 weeks of daily dosing Time to Results: 2–4 weeks for sleep improvement; 8–12 weeks for body composition changes Washout: 1–2 weeks
Storage
Lyophilized: −20 °C (−4 °F) Reconstituted: 2–8 °C (35.6–46.4 °F) Shelf Life: 28 days
Injection Sites
Abdomen, Thigh
Safety & Contraindications
Safety: Generally well-tolerated in clinical studies; safety data from published trials supports good tolerability profile Common: injection site reactions (redness, swelling, mild pain — typically resolve within days) Systemic: headaches, nausea, dizziness, facial flushing, drowsiness (mild, transient, usually in initial weeks as the body adjusts)
Contraindications: Active malignancy or active cancer (GH promotes cell proliferation); Pregnancy and breastfeeding; Pituitary disorders or prior pituitary surgery
Related Products
Sermorelin 5mg
5mg
Related Research News
Sermorelin Effects on Pituitary and Testicular Cells
Sermorelin, a 29-amino-acid analog of growth hormone-releasing hormone, activates receptors on anterior pituitary cells to boost hGH secretion roughly twofold, from 1.1 to 2.2 μg/L over 12 hours. Studies show this leads to IGF-1 increases of 27-28% and may enhance testosterone production in Leydig cells via upregulated IGF-1. Lab experiments highlight cAMP-PKA signaling and calcium-dependent mechanisms driving these responses.
Synergistic Growth Hormone Effects of Sermorelin and Ipamorelin Blend
Research peptides Sermorelin and Ipamorelin may work together to boost growth hormone release from pituitary cells through distinct pathways. Sermorelin mimics the active part of natural GHRH, while Ipamorelin targets GHS-R1a receptors selectively. Laboratory studies indicate this combination could produce higher hGH peaks than either alone, with potential anabolic benefits via IGF-1.